Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action weight-loss and diabetes drug into the country.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback